Nanalysis Scientific (CVE:NSCI) Shares Up 12.5% – Still a Buy?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report) shot up 12.5% during mid-day trading on Wednesday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 241,165 shares changed hands during trading, an increase of 285% from the average session volume of 62,690 shares. The stock had previously closed at C$0.12.

Nanalysis Scientific Trading Up 12.5%

The company has a quick ratio of 1.10, a current ratio of 1.42 and a debt-to-equity ratio of 71.72. The firm has a market capitalization of C$18.69 million, a PE ratio of -2.70 and a beta of -0.52. The stock’s fifty day simple moving average is C$0.14 and its 200 day simple moving average is C$0.15.

Nanalysis Scientific Company Profile

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.

Read More

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.